Editor's Note
World Health Organization evaluated the agency’s first-ever review of the health and safety of cannabis and found that it is a “relatively safe drug” that millions of people are already using to help manage a wide range of medical conditions. The report, which is derived from a survey of 953 cannabis patients from 31 countries, noted “Barriers to research in the USA include the difficulty of navigating through several federal agencies (including the aforementioned DEA, FDA), as well as research ethics boards and local and state oversight concerns. There are also issues related to quality, quantity, and kind of product available from the current single federal source of cannabis for research use and the lack of adequate funding sources.”
The World Health Organization met in Geneva, Switzerland, last week to review the agency’s first-ever review of the health and safety of cannabis.

It’s an early step as the global health agency, an office of the United Nations, prepares to issue a recommendation to the UN on the “need for and level of international control” over the plant, which is broadly prohibited under international drug treaties.

The top-level takeaway: Cannabis, the report found, is a “relatively safe drug” that millions of people are already using to help manage a wide range of medical conditions.